225 related articles for article (PubMed ID: 23761400)
1. Smad7 inhibits angiotensin II-induced hypertensive cardiac remodelling.
Wei LH; Huang XR; Zhang Y; Li YQ; Chen HY; Yan BP; Yu CM; Lan HY
Cardiovasc Res; 2013 Sep; 99(4):665-73. PubMed ID: 23761400
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Smad7 enhances cardiac remodeling induced by angiotensin II infusion in a mouse model of hypertension.
Wei LH; Huang XR; Zhang Y; Li YQ; Chen HY; Heuchel R; Yan BP; Yu CM; Lan HY
PLoS One; 2013; 8(7):e70195. PubMed ID: 23894614
[TBL] [Abstract][Full Text] [Related]
3. Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension.
Liu GX; Li YQ; Huang XR; Wei LH; Zhang Y; Feng M; Meng XM; Chen HY; Shi YJ; Lan HY
Clin Sci (Lond); 2014 Aug; 127(3):195-208. PubMed ID: 24511990
[TBL] [Abstract][Full Text] [Related]
4. Disruption of Smad7 promotes ANG II-mediated renal inflammation and fibrosis via Sp1-TGF-β/Smad3-NF.κB-dependent mechanisms in mice.
Liu GX; Li YQ; Huang XR; Wei L; Chen HY; Shi YJ; Heuchel RL; Lan HY
PLoS One; 2013; 8(1):e53573. PubMed ID: 23301086
[TBL] [Abstract][Full Text] [Related]
5. Smad3 mediates ANG II-induced hypertensive kidney disease in mice.
Liu Z; Huang XR; Lan HY
Am J Physiol Renal Physiol; 2012 Apr; 302(8):F986-97. PubMed ID: 22237801
[TBL] [Abstract][Full Text] [Related]
6. Smad3 mediates cardiac inflammation and fibrosis in angiotensin II-induced hypertensive cardiac remodeling.
Huang XR; Chung AC; Yang F; Yue W; Deng C; Lau CP; Tse HF; Lan HY
Hypertension; 2010 May; 55(5):1165-71. PubMed ID: 20231525
[TBL] [Abstract][Full Text] [Related]
7. Deletion of Angiotensin-Converting Enzyme-2 Promotes Hypertensive Nephropathy by Targeting Smad7 for Ubiquitin Degradation.
Liu Z; Huang XR; Chen HY; Fung E; Liu J; Lan HY
Hypertension; 2017 Oct; 70(4):822-830. PubMed ID: 28808068
[TBL] [Abstract][Full Text] [Related]
8. Baicalein attenuates angiotensin II-induced cardiac remodeling via inhibition of AKT/mTOR, ERK1/2, NF-κB, and calcineurin signaling pathways in mice.
Wang AW; Song L; Miao J; Wang HX; Tian C; Jiang X; Han QY; Yu L; Liu Y; Du J; Xia YL; Li HH
Am J Hypertens; 2015 Apr; 28(4):518-26. PubMed ID: 25362112
[TBL] [Abstract][Full Text] [Related]
9. C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.
Zhang R; Zhang YY; Huang XR; Wu Y; Chung AC; Wu EX; Szalai AJ; Wong BC; Lau CP; Lan HY
Hypertension; 2010 Apr; 55(4):953-60. PubMed ID: 20157054
[TBL] [Abstract][Full Text] [Related]
10. Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy.
Liu Z; Huang XR; Chen HY; Penninger JM; Lan HY
Lab Invest; 2012 May; 92(5):650-61. PubMed ID: 22330342
[TBL] [Abstract][Full Text] [Related]
11. Repression of transforming-growth-factor-beta-mediated transcription by nuclear factor kappaB.
Nagarajan RP; Chen F; Li W; Vig E; Harrington MA; Nakshatri H; Chen Y
Biochem J; 2000 Jun; 348 Pt 3(Pt 3):591-6. PubMed ID: 10839991
[TBL] [Abstract][Full Text] [Related]
12. Smad7 gene therapy ameliorates an autoimmune crescentic glomerulonephritis in mice.
Ka SM; Huang XR; Lan HY; Tsai PY; Yang SM; Shui HA; Chen A
J Am Soc Nephrol; 2007 Jun; 18(6):1777-88. PubMed ID: 17475816
[TBL] [Abstract][Full Text] [Related]
13. MiR-101a ameliorates AngII-mediated hypertensive nephropathy by blockade of TGFβ/Smad3 and NF-κB signalling in a mouse model of hypertension.
Ding H; Zhou Y; Huang H
Clin Exp Pharmacol Physiol; 2019 Mar; 46(3):246-254. PubMed ID: 30304543
[TBL] [Abstract][Full Text] [Related]
14. Sp1 Mediates a Therapeutic Role of MiR-7a/b in Angiotensin II-Induced Cardiac Fibrosis via Mechanism Involving the TGF-β and MAPKs Pathways in Cardiac Fibroblasts.
Li R; Xiao J; Qing X; Xing J; Xia Y; Qi J; Liu X; Zhang S; Sheng X; Zhang X; Ji X
PLoS One; 2015; 10(4):e0125513. PubMed ID: 25923922
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Hypertensive Heart Disease by Targeting Smad3 Signaling in Mice.
Meng J; Qin Y; Chen J; Wei L; Huang XR; Yu X; Lan HY
Mol Ther Methods Clin Dev; 2020 Sep; 18():791-802. PubMed ID: 32953930
[TBL] [Abstract][Full Text] [Related]
16. Signaling mechanism of TGF-beta1 in prevention of renal inflammation: role of Smad7.
Wang W; Huang XR; Li AG; Liu F; Li JH; Truong LD; Wang XJ; Lan HY
J Am Soc Nephrol; 2005 May; 16(5):1371-83. PubMed ID: 15788474
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin II promotes the proliferation of activated pancreatic stellate cells by Smad7 induction through a protein kinase C pathway.
Hama K; Ohnishi H; Aoki H; Kita H; Yamamoto H; Osawa H; Sato K; Tamada K; Mashima H; Yasuda H; Sugano K
Biochem Biophys Res Commun; 2006 Feb; 340(3):742-50. PubMed ID: 16380081
[TBL] [Abstract][Full Text] [Related]
18. PPAR alpha activator fenofibrate inhibits myocardial inflammation and fibrosis in angiotensin II-infused rats.
Diep QN; Benkirane K; Amiri F; Cohn JS; Endemann D; Schiffrin EL
J Mol Cell Cardiol; 2004 Feb; 36(2):295-304. PubMed ID: 14871557
[TBL] [Abstract][Full Text] [Related]
19. Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro.
Meng XM; Huang XR; Xiao J; Chung AC; Qin W; Chen HY; Lan HY
Kidney Int; 2012 Feb; 81(3):266-79. PubMed ID: 22048127
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor-β/Smad signalling in diabetic nephropathy.
Lan HY
Clin Exp Pharmacol Physiol; 2012 Aug; 39(8):731-8. PubMed ID: 22211842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
